480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)

Clinical trial NCT00953589 · COMPLETED

Trial details

NCT number: NCT00953589
Sponsor: Biolex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2009-07-01
Primary completion: 2010-05-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.